Boehringer Ingelheim Pharmaceuticals, Inc. recalls

1 recalls.

• Synjardy XR Tablets recall (Boehringer Ingelheim Pharmaceuticals, Inc.)
  DrugClass IIReported July 8, 2026 · CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a...